Toggle Main Menu Toggle Search

Open Access padlockePrints

Quality of life of X-linked agammaglobulinemia patients in the United Kingdom

Lookup NU author(s): Dr Ben ShillitoeORCiD, Dr Catherine Stroud, Dr Terence Flood, Professor Mark PearceORCiD, Professor Andrew GenneryORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

© 2026 Shillitoe et al. Due to limitations in current therapies (immunoglobulin replacement therapy), complications in X-linked agammaglobulinemia (XLA) such as bronchiectasis may continue to occur, with subsequent significant impacts on healthrelated quality of life (HRQoL). There were no significant differences in PedsQL 4.0 total scores against UK healthy norms (self 80.98, P = 0.277; parent 79.76, P = 0.465). There were no significant differences in the SF36v2 physical component score (PCS) against UK healthy norms (49.10, P = 0.712). However, XLA patients with bronchiectasis had significantly worse PCS than patients without (47.88 versus 55.14, P < 0.001) and significantly worse PCS than UK healthy norms (P = 0.004). In the absence of bronchiectasis, HRQoL is comparable to UK healthy norms. However, XLA patients with bronchiectasis have significantly worse HRQoL than patients without bronchiectasis and UK healthy norms. These data demonstrate that further work into novel therapies are needed to prevent bronchiectasis to enable XLA patients to have a normal quality of life.


Publication metadata

Author(s): Shillitoe B, Bourne H, Stroud C, Flood T, Buckland M, Ip W, Worth A, Hackett S, Herwadkar A, Coulter T, Jolles S, Garcez T, Moya E, Faust SN, Pearce MS, Gennery AR

Publication type: Article

Publication status: Published

Journal: Journal of Human Immunity

Year: 2026

Volume: 2

Issue: 3

Print publication date: 04/05/2026

Online publication date: 19/02/2026

Acceptance date: 06/02/2026

Date deposited: 01/06/2026

ISSN (electronic): 3065-8993

Publisher: Rockefeller University Press

URL: https://doi.org/10.70962/jhi.20250198

DOI: 10.70962/jhi.20250198

Data Access Statement: All relevant data that can be shared can be found in supplemental material. Additional data are available from the corresponding author upon reasonable request from health care professionals and within national General Data Protection Regulation rules and regulations.


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
Bubble Foundation
Jeffrey Modell Foundation

Share